Imatinib therapy of chronic myeloid leukemia significantly reduces carnitine cell intake, resulting in adverse events
Titel:
Imatinib therapy of chronic myeloid leukemia significantly reduces carnitine cell intake, resulting in adverse events
Auteur:
Burda, Pavel Hlavackova, Alzbeta Polivkova, Vendula Curik, Nikola Laznicka, Adam Krizkova, Jitka Suttnar, Jiri Klener, Pavel Polakova, Katerina Machova